Forte Biosciences | 10-Q:季度报表
Forte Biosciences | 8-K:FORTE BIOSCIENCES, INC.公布2024年第一季度业绩并提供业务最新情况
Forte Biosciences | 10-K/A:年度报表(修正版)
Forte Biosciences | S-8:员工福利计划证券登记
Forte Biosciences | 4:持股变动声明-高管 Riley Antony A
Forte Biosciences | 4:持股变动声明-高管 Wagner Paul A.
Forte Biosciences | 4:持股变动声明-董事 FINCK BARBARA K
Forte Biosciences | 4:持股变动声明-高管 Riley Antony A
Forte Biosciences | 4:持股变动声明-高管 Wagner Paul A.
Forte Biosciences | 10-K:年度报表
Forte Biosciences | 8-K:重大事件
Forte Biosciences | 8-K/A:重大事件(修正)
Forte Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(9.9%),Joseph Edelman(9.9%)等
Forte Biosciences | SC 13G:超过5%持股股东披露文件-TYBOURNE CAPITAL MANAGEMENT (HK) LIMITED(9.99%),TYBOURNE STRATEGIC OPPORTUNITIES GP II LIMITED(9.99%)等
Forte Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Alger Associates, Inc.(5.1%)
Forte Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Joshua J. Dapice(9.9%),Philip D. Dreyfuss(9.9%)等
Forte Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-BML Investment Partners, L.P.(4.8%)
Forte Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-Funicular Funds, LP(5.59%),Jacob Ma-Weaver(5.59%)
Forte Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-Camac Partners, LLC(4.3%),Camac Capital, LLC(4.3%)等
Forte Biosciences | 4:持股变动声明-高管 Chen Hubert C
暂无数据